1 January 2020 in Computers, Materials & Continua
The virus SARS-CoV2, which causes coronavirus disease (COVID-19) has become a pandemic and has spread to every inhabited continent. Given the increasing caseload, there is an urgent need to augment clinical skills in order to identify from among the many mild cases the few that will progress to critical illness. We present a first step towards building an artificial intelligence (AI) framework, with predictive analytics (PA) capabilities applied to real patient data, to provide rapid clinical decision-making support. COVID-19 has presented a pressing need as a) clinicians are still developing clinical acumen to this novel disease and b) resource limitations in a surging pandemic require difficult resource allocation decisions. The objectives of this research are: (1) to algorithmically identify the combinations of clinical characteristics of COVID-19 that predict outcomes, and (2) to develop a tool with AI capabilities that will predict patients at risk for more severe illness on initial presentation. The predictive models learn from historical data to help predict who will develop acute respiratory distress syndrome (ARDS), a severe outcome in COVID-19. Our results, based on data from two hospitals in Wenzhou, Zhejiang, China, identified features on initial presentation with COVID-19 that were most predictive of later development of ARDS. A mildly elevated alanine aminotransferase (ALT) (a liver enzyme), the presence of myalgias (body aches), and an elevated hemoglobin (red blood cells), in this order, are the clinical features, on presentation, that are the most predictive. The predictive models that learned from historical data of patients from these two hospitals achieved 70% to 80% accuracy in predicting severe cases.
17 February 2022 in PLOS Digital Health
HCHelle Collatz Christensen
Helle Collatz Christensen
OIOn Behalf Of The Z-Inspection Initiative
On Behalf Of The Z-Inspection Initiative
+9
Explainability for artificial intelligence (AI) in medicine is a hotly debated topic. Our paper presents a review of the key arguments in favor and against explainability for AI-powered Clinical Decision Support System (CDSS) applied to a concrete use case, namely an AI-powered CDSS currently used in the emergency call setting to identify patients with life-threatening cardiac arrest. More specifically, we performed a normative analysis using socio-technical scenarios to provide a nuanced account of the role of explainability for CDSSs for the concrete use case, allowing for abstractions to a more general level. Our analysis focused on three layers: technical considerations, human factors, and the designated system role in decision-making. Our findings suggest that whether explainability can provide added value to CDSS depends on several key questions: technical feasibility, the level of validation in case of explainable algorithms, the characteristics of the context in which the system is implemented, the designated role in the decision-making process, and the key user group(s). Thus, each CDSS will require an individualized assessment of explainability needs and we provide an example of how such an assessment could look like in practice.
1 November 2005 in Epidemiology
The emergence and rapid global spread of the severe acute respiratory syndrome (SARS) coronavirus in 2002–2003 prompted efforts by modelers to characterize SARS epidemiology and inform control policies. We overview and discuss models for emerging infectious diseases (EIDs), provide a critical survey of SARS modeling literature, and discuss promising future directions for research. We reconcile discrepancies between published estimates of the basic reproductive number R0 for SARS (a crucial epidemiologic parameter), discuss insights regarding SARS control measures that have emerged uniquely from a modeling approach, and argue that high priorities for future modeling of SARS and similar respiratory EIDs should include informing quarantine policy and better understanding the impact of population heterogeneity on transmission patterns.
1 February 2005 in The Journal of Infectious Diseases
BackgroundHigh rates of population movement may have helped spread human immunodeficiency virus (HIV) in southern Africa, including Zimbabwe, but whether mobility continues to influence the epidemic is unclear MethodsThe relationship between movement, risk behaviors, and prevalence of HIV was assessed from a general population survey of >9800 adults in 12 rural communities in Manicaland province in eastern Zimbabwe ResultsHIV prevalence varied with socioeconomic development. In community centers, prevalence among women was 49.9% (95% confidence interval [CI], 46.1%–53.6%), compared with 24.7% (95% CI, 22.6%–26.7%) in the least-developed subsistence-farming areas. Mobility was not associated with risk of HIV infection, except for those who migrated between rural locations. Among migrant agricultural workers, prevalence was 38.8% (95% CI, 33.1%–44.6%) for women and 26.4% (95% CI, 23.8%–28.9%) for men, compared with 29.7% (95% CI, 28.3%–31.1%) and 20.9% (95% CI, 19.3%–22.4%) for other sexually active women and men, respectively. Risk was increased if an individual traveled to Harare in the last month, without their spouse, but this risk was not transferred to the partner ConclusionRural-urban migration does not appear to be responsible for maintaining the high HIV prevalence in rural Zimbabwe, but rates of HIV infection may be affected by rural-rural migration
1 August 1998 in Radiation Research
This study was undertaken to determine if acidic or basic fibroblast growth factor (FGF1 or FGF2) or vascular endothelial growth factor (VEGF) alters the radiat...